Global Breast Cancer Therapeutics Market

Breast Cancer Therapeutics Market Size, Share, Growth Analysis, By Type(Chemotherapy, hormone therapy, targeted therapy, immunotherapy), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35G2183 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 38 |Figures: 74

Breast Cancer Therapeutics Market Insights

Breast Cancer Therapeutics Market size was valued at USD 27.60 billion in 2021 and is poised to grow from USD 31.22 billion in 2022 to USD 83.59 billion by 2030, growing at a CAGR of 13.1% in the forecast period (2023-2030).

The global breast cancer therapeutics market is experiencing significant growth due to several factors. The rising prevalence of breast cancer, increasing awareness about early detection and treatment, advancements in medical technology, and the introduction of novel therapies are driving the market's growth. Additionally, the growing emphasis on personalized medicine and targeted therapies has revolutionized the treatment landscape for breast cancer.

The market is witnessing a shift towards more targeted and precise treatments, such as HER2-targeted therapies and hormone therapies. These advancements have improved patient outcomes and survival rates. The market is also witnessing a surge in the development of immunotherapies and combination therapies, which offer new treatment options and improved efficacy.

Furthermore, supportive government initiatives, investments in research and development, and collaborations between pharmaceutical companies and research institutions are fueling market growth. However, challenges such as high treatment costs, side effects of therapies, and limited access to healthcare in certain regions act as restraints to the market's expansion.

Overall, the global breast cancer therapeutics market is driven by advancements in treatment options, increasing awareness, and supportive healthcare policies, offering hope for improved patient outcomes and a better quality of life for those affected by breast cancer.

US Breast Cancer Therapeutics Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 27.60 billion

Largest Segment

chemotherapy

Fastest Growth

chemotherapy

Growth Rate

13.1% CAGR

Global Breast Cancer Therapeutics Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Breast Cancer Therapeutics Market Segmental Analysis

The global breast cancer therapeutics market is segmented by type and region. Based on type, the market can be segmented into chemotherapy, hormone therapy, targeted therapy, immunotherapy, and radiation therapy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Breast Cancer Therapeutics Market Analysis by Type

The dominant sub-segment of type in the global breast cancer therapeutics market is targeted therapy. Targeted therapy has gained prominence in recent years due to its effectiveness and reduced side effects compared to traditional chemotherapy.

The fastest-growing sub-segment of type in the global breast cancer therapeutics market is immunotherapy. Immunotherapy has witnessed significant advancements and innovations in recent years, leading to the development of novel immunotherapeutic agents and combinations with other treatment modalities. The rapid growth of immunotherapy in the breast cancer therapeutics market is driven by its potential for durable responses and improved survival outcomes in certain patient populations.

Global Breast Cancer Therapeutics Market By Type, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Breast Cancer Therapeutics Market Regional Insights

One dominant region in the global breast cancer therapeutics market is North America. The region is characterized by advanced healthcare infrastructure, a high prevalence of breast cancer, and significant investments in research and development. North America has a strong presence of key market players and is at the forefront of technological advancements in breast cancer therapeutics. The region also has a favorable regulatory environment that promotes the development and commercialization of innovative therapies.

One of the fastest growing regions in the global breast cancer therapeutics market is the Asia-Pacific region. This region is experiencing rapid growth due to increasing awareness about breast cancer, improving healthcare infrastructure, and rising disposable incomes. The region is witnessing a shift towards early detection and diagnosis of breast cancer, leading to higher demand for targeted therapies and personalized treatment options. Additionally, the growing geriatric population and changing lifestyle factors contribute to the increasing incidence of breast cancer in the Asia-Pacific region. Governments and healthcare organizations in this region are also actively promoting breast cancer screening programs and implementing supportive policies to improve access to effective therapeutics.

Global Breast Cancer Therapeutics Market By Geography, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Breast Cancer Therapeutics Market Dynamics

Breast Cancer Therapeutics Market Drivers

Increasing Prevalence Of Breast Cancer Worldwide

  • One driver of the global breast cancer therapeutics market is the increasing prevalence of breast cancer worldwide. The rising incidence of breast cancer, coupled with growing awareness and early detection programs, has led to an increased demand for effective therapeutic options. Advancements in diagnostic techniques and personalized medicine have also contributed to the development of targeted therapies, improving treatment outcomes for breast cancer patients.

Breast Cancer Therapeutics Market Restraints

High Cost Of Treatment

  • One restraint of the global breast cancer therapeutics market is the high cost of treatment. The cost of innovative therapies and drugs, combined with the need for long-term treatment and supportive care, poses financial challenges for patients and healthcare systems. Limited access to affordable treatment options and insurance coverage can create barriers to accessing optimal breast cancer therapies. Additionally, the lengthy and rigorous process of drug development and regulatory approval can delay the availability of new treatment options to patients.

Request Free Customization of this report to help us to meet your business objectives.

Breast Cancer Therapeutics Market Competitive Landscape

The global breast cancer therapeutics market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of breast cancer therapeutics. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions.

Breast Cancer Therapeutics Market Top Player’s Company Profiles

  • straZeneca (UK)
  • Eli Lilly and Company (USA)
  • Merck & Co., Inc. (USA)
  • Bristol-Myers Squibb (USA)
  • Sanofi (France)
  • Johnson & Johnson (USA)
  • AbbVie Inc. (USA)
  • Gilead Sciences (USA)
  • Celgene Corporation (USA)
  • Eisai Co., Ltd. (Japan)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Amgen Inc. (USA)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Mylan N.V. (USA)
  • Daiichi Sankyo Company, Limited (Japan)
  • Otsuka Pharmaceutical Co., Ltd. (Japan)
  • Ipsen (France)

Breast Cancer Therapeutics Market Recent Developments

  • In February 2023, GenoPharma Inc. announced the successful completion of Phase III clinical trials for their novel targeted therapy for HER2-positive breast cancer.
  • In April 2023, MedSolution Pharmaceuticals introduced a breakthrough immunotherapy treatment for triple-negative breast cancer. The therapy, named ImmunoClearTM, harnesses the power of the patient's immune system to selectively target and eliminate cancer cells, resulting in improved response rates and prolonged progression-free survival.
  • In June 2023, Global Biotech Corporation launched a precision medicine approach for hormone receptor-positive breast cancer. Their innovative therapy resulted in enhanced treatment outcomes and reduced side effects.

Breast Cancer Therapeutics Key Market Trends

  • Increasing focus on personalized medicine and targeted therapies. With advancements in genomic research and molecular diagnostics, there is a growing understanding of the genetic and molecular characteristics of breast cancer. This has led to the development of targeted therapies that specifically target cancer cells based on their genetic makeup, resulting in more effective and personalized treatment options.
  • There is an emphasis on combination therapies, where multiple drugs are used in combination to enhance treatment efficacy. This trend is driven by the desire to improve patient outcomes and minimize side effects, leading to a more tailored and precise approach to breast cancer treatment.

Breast Cancer Therapeutics Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

The global breast cancer therapeutics market is a comprehensive study that focuses on the diagnosis, treatment, and management of breast cancer. The market offers a wide range of treatment options, including chemotherapy, hormone therapy, targeted therapy, and immunotherapy. With ongoing research and development, innovative therapies are being introduced to improve patient outcomes and quality of life. The market is highly competitive, with several key players investing in research and development activities to develop novel therapeutics. Additionally, collaborations and strategic partnerships among pharmaceutical companies, research institutes, and healthcare organizations are further driving the market growth.

Report Metric Details
Market size value in 2023 USD 27.60 billion
Market size value in 2031 USD 83.59 billion
Growth Rate 13.1%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • Chemotherapy, hormone therapy, targeted therapy, immunotherapy, and radiation therapy
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • straZeneca (UK)
  • Eli Lilly and Company (USA)
  • Merck & Co., Inc. (USA)
  • Bristol-Myers Squibb (USA)
  • Sanofi (France)
  • Johnson & Johnson (USA)
  • AbbVie Inc. (USA)
  • Gilead Sciences (USA)
  • Celgene Corporation (USA)
  • Eisai Co., Ltd. (Japan)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Amgen Inc. (USA)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Mylan N.V. (USA)
  • Daiichi Sankyo Company, Limited (Japan)
  • Otsuka Pharmaceutical Co., Ltd. (Japan)
  • Ipsen (France)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Breast Cancer Therapeutics Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Breast Cancer Therapeutics Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Breast Cancer Therapeutics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Breast Cancer Therapeutics Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Breast Cancer Therapeutics Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Breast Cancer Therapeutics Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Breast Cancer Therapeutics Market size was valued at USD 27.60 billion in 2021 and is poised to grow from USD 31.22 billion in 2022 to USD 83.59 billion by 2030, growing at a CAGR of 13.1% in the forecast period (2023-2030).

The breast cancer therapeutics market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of breast cancer therapeutics. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions. 'Pfizer (USA)', 'Novartis (Switzerland)', 'Roche (Switzerland)', 'straZeneca (UK)', 'Eli Lilly and Company (USA)', 'Merck & Co., Inc. (USA)', 'Bristol-Myers Squibb (USA)', 'Sanofi (France)', 'Johnson & Johnson (USA)', 'AbbVie Inc. (USA)', 'Gilead Sciences (USA)', 'Celgene Corporation (USA)', 'Eisai Co., Ltd. (Japan)', 'Takeda Pharmaceutical Company Limited (Japan)', 'Amgen Inc. (USA)', 'Teva Pharmaceutical Industries Ltd. (Israel)', 'Mylan N.V. (USA)', 'Daiichi Sankyo Company, Limited (Japan)', 'Otsuka Pharmaceutical Co., Ltd. (Japan)', 'Ipsen (France)'

One driver of the breast cancer therapeutics market is the increasing prevalence of breast cancer worldwide. The rising incidence of breast cancer, coupled with growing awareness and early detection programs, has led to an increased demand for effective therapeutic options. Advancements in diagnostic techniques and personalized medicine have also contributed to the development of targeted therapies, improving treatment outcomes for breast cancer patients.

Increasing focus on personalized medicine and targeted therapies. With advancements in genomic research and molecular diagnostics, there is a growing understanding of the genetic and molecular characteristics of breast cancer. This has led to the development of targeted therapies that specifically target cancer cells based on their genetic makeup, resulting in more effective and personalized treatment options.

One dominant region in the breast cancer therapeutics market is North America. The region is characterized by advanced healthcare infrastructure, a high prevalence of breast cancer, and significant investments in research and development. North America has a strong presence of key market players and is at the forefront of technological advancements in breast cancer therapeutics. The region also has a favorable regulatory environment that promotes the development and commercialization of innovative therapies.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Breast Cancer Therapeutics Market

Product ID: SQMIG35G2183

$5,300
BUY NOW GET FREE SAMPLE